Biotech Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases August 5, 2026
Biotech Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update August 5, 2026
Biotech Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program August 5, 2026
Biotech Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X August 5, 2026
Biotech IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update August 4, 2026
Biotech SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies August 4, 2026
Biotech CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) August 4, 2026
Biotech Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference August 3, 2026
Biotech Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs July 31, 2026
Search
Biotech
August 5, 2026
August 5, 2026
August 5, 2026
August 5, 2026
August 4, 2026
August 4, 2026
August 4, 2026
August 4, 2026
August 3, 2026
July 31, 2026
